VALOR, an adaptive design, pivotal phase III trial of vosaroxin or placebo in combination with cytarabine in first relapsed or refractory acute myeloid leukemia


Conference Paper

Full Text

Duke Authors

Cited Authors

  • Ravandi, F; Ritchie, EK; Sayar, H; Strickland, SA; Craig, M; Selleslag, DLD; Maertens, J; Havelange, V; Lancet, JE; Ketchum, SB; Acton, G; Mehta, CR; Silva, E; Craig, A; Fox, JA; Stuart, RK; Erba, HP; Vey, N; Schiller, GJ; Feldman, EJ

Published Date

  • May 20, 2012

Published In

Volume / Issue

  • 30 / 15

Published By


  • 1

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Conference Name

  • 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)

Conference Location

  • Chicago, IL

Conference Start Date

  • June 1, 2012

Conference End Date

  • June 6, 2012